Resultados de procura - Amy O. Johnson‐Levonas

  • Mostrando 1 - 8 Resultados de 8
Limitar resultados
  1. 1
    Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study

    Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin mon... por Michel Farnier, Maurizio Averna, Luc Missault, H Vaverková, Margus Viigimaa, Rachid Massaad, K. Vandormael, Amy O. Johnson‐Levonas, Philippe Brudi

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

    Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib por Ronald M. Krauss, Kathleen Wojnooski, Joseph Orr, J. Casey Geaney, Cathy Anne Pinto, Yang Liu, John A. Wagner, Julie Mabalot Luk, Amy O. Johnson‐Levonas, Matt S. Anderson, Hayes M. Dansky

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)

    A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML) por Farhad Ravandi, Ivana Gojo, Mrinal M. Patnaik, Mark D. Minden, Hagop M. Kantarjian, Amy O. Johnson‐Levonas, Craig Fancourt, Raymond W. Lam, Mary Jones, Clayton D. Knox, Shelonitda Rose, Payal Patel, Raoul Tibes

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors

    Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors por Andrew J. Wagner, Udai Banerji, Amit Mahipal, Neeta Somaiah, Heather A. Hirsch, Craig Fancourt, Amy O. Johnson‐Levonas, Raymond W. Lam, Amy Meister, Giuseppe Lo Russo, Clayton D. Knox, Shelonitda Rose, David S. Hong

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol

    A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low... por Christie M. Ballantyne, Sukrut Shah, Aditi Sapre, Tanya B. Ashraf, Sandra C. Tobias, Tayfun Şahı̇n, Ping Ye, Yugang Dong, Wayne Huey-Heng Sheu, Duk‐Hyun Kang, Paulo Roberto Ferreira ROSSI, Yulia Moiseeva, Ignacio Rodríguez Briones, Amy O. Johnson‐Levonas, Yale Mitchel

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects

    CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects por Tiffany Thomas, Haihong Zhou, Wahida Karmally, Rajasekhar Ramakrishnan, Stephen Holleran, Yang Liu, Patricia Jumes, John A. Wagner, Brian K. Hubbard, Stephen F. Previs, Thomas P. Roddy, Amy O. Johnson‐Levonas, David E. Gutstein, Santica M. Marcovina, Daniel J. Rader, Henry N. Ginsberg, John S. Millar, Gissette Reyes‐Soffer

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial

    Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial por Rogério Souza, David B. Badesch, Hossein Ardeschir Ghofrani, J. Simon R. Gibbs, Mardi Gomberg‐Maitland, Vallerie V. McLaughlin, Ioana R. Preston, Aaron B. Waxman, Ekkehard Grünig, Grzegorz Kopeć, Gisela Meyer, Karen M. Olsson, Stephan Rosenkranz, Jianxin Lin, Amy O. Johnson‐Levonas, Janethe de Oliveira Pena, Marc Humbert, Marius M. Hoeper

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

    Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects por John S. Millar, Gissette Reyes‐Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson‐Levonas, John A. Wagner, Stephen Holleran, Joseph C. Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: